[Behaviour of ujoviridin exposure test (ICG) in conjunction with application of hormonal contraceptives (author's transl)].
The effects of Ovosiston, Non-Ovlon, Anacyclin, Eugynon, and Deposiston, all oral hormonal contraceptives, on 75 women in fertile age and on the half-life of Ujoviridin (ICG - indocyanine green) were studied prior to treatment as well as late in the second, sixth, and twelfth cycles of treatment. ICG half-life was found to be extended in the adaptation phase only in response to Deposiston. ICG is recommended for time-related diagnosis of liver changes in women on hormonal contraceptives.
D000293:Adolescent; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects; D005260:Female; D006207:Half-Life; D006801:Humans; D007208:Indocyanine Green; D008107:Liver Diseases / Q000175:diagnosis
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003279:Contraceptives, Oral, Sequential; D007208:Indocyanine Green
Das Verhalten des Ujoviridin-(ICG)-Belastungstests unter der Applikation hormonaler Kontrazeptiva.